Leanne Kelly - May 11, 2021 Form 3 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role: Chief Financial Officer
Signature: /s/ David Baker, attorney-in-fact
Stock symbol: GRI
Transactions as of: May 11, 2021
Transactions value $: $0
Form type: 3
Date filed: 5/18/2021, 04:05 PM
Next filing: May 18, 2021

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney